Side effects, images, and drug details for Actemra ACTPen - Inside Rx
Back to Search Results

Actemra ACTPen

tocilizumab
Tocilizumab is used to treat moderate to severe rheumatoid arthritis in adults after at least one other medication did not work or has stopped working. Tocilizumab is also used in adults to treat giant cell arteritis, or inflammation of the lining of your arteries (blood vessels that carry blood from your heart to other parts of your body). Tocilizumab is used to treat polyarticular juvenile idiopathic arthritis in adults and children ages 2 and older. Tocilizumab is also used to treat systemic juvenile idiopathic arthritis (or "Still disease") in adults and children ages 2 and older. Tocilizumab is also used to treat severe or life-threatening cytokine release syndrome (CRS) caused by an overactive immune response to certain types of blood cell treatments for cancer. Tocilizumab is used for CRS in adults and children ages 2 and older. Tocilizumab is sometimes given together with other medications as part of your complete treatment. Tocilizumab may also be used for purposes not listed in this medication guide.
CHEMICAL NAME
tocilizumab
DRUG TYPE
interleukin inhibitors

Frequently Asked Questions

Tocilizumab affects your immune system. You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, chills, aches, tiredness, cough, skin sores, diarrhea, weight loss, or burning when you urinate.

Tocilizumab may also cause a perforation (a hole or tear) in your stomach or intestines. Tell your doctor if you have a fever and stomach pain with a change in your bowel habits.

Tocilizumab may also cause liver problems. Tell your doctor right away if you have right-sided stomach pain, vomiting, loss of appetite, tiredness, dark urine, clay-colored stools, or yellowing of your skin or eyes.

Similar Drugs

Brand Name Examples Supplied As Strength
Actemra solution 162 mg/0.9 mL
Actemra ACTPen solution 162 mg/0.9 mL

Save up to 80% on brand & generic medications.